Results 241 to 250 of about 107,212 (296)

Isolated cardiac sarcoidosis presenting as tumour-like multiple cardiac masses with massive pericardial effusion. [PDF]

Eur Heart J Case Rep
Yamada M, Ueno K.
europepmc   +1 more source

Hypereosinophilic syndrome presenting as pleural and pericardial effusion in a Pediatric patient: a rare case report. [PDF]

Oxf Med Case Reports
Dhenga S, Pokhrel M, Rauniyar S, Shrestha B, Pandey A, Magar SA.   +5 more
europepmc   +1 more source

Pericardial effusion

, 2020
openaire   +1 more source

Recurrent Malignant Pericardial Effusion Management: The Pericardio-Peritoneal Window. [PDF]

J Clin Med
Mazzella A, Caffarena G, Bardoni C, Nicolosi G, Maisonneuve P, Cerretani G, Sedda G, Bertolaccini L, Lo Iacono G, Casiraghi M, Spaggiari L.   +10 more
europepmc   +1 more source

Identification of a Novel De Novo HECW2 Gene Pathogenic Variant in a Fetus With Cardiac Abnormalities

Prenatal Diagnosis, Volume 46, Issue 10, Page 1663-1666, September 2026.
Kristina Nimchenko, Bettina Bessieres, Gihad E. Chalouhi, Antonia Pop, Vanina Castaigne, Bertrand Stos, Marie‐Paule Beaujard, Diane Roy, Daniela Laux, Tania Attie‐Bitach   +9 more
wiley   +1 more source

Malignant Pericardial Effusion

Cardiology, 2013
Malignant pericardial effusion is a common and serious manifestation in malignancies. The origins of the malignant process include solid tumors or hematological malignancies, while primary neoplasms of the pericardium are less common. In the oncological patient, pericardial effusion may develop by several different mechanisms, namely by direct or ...
Burazor I, Imazio M, Markel G, Adler Y
openaire   +4 more sources

Post-cardiac injury syndrome and pericardial effusion recurrence after pericardial effusion drainage in chronic idiopathic pericardial effusion

European Journal of Internal Medicine
Introduction: The management of even large pericardial effusions in asymptomatic patients is still a matter of debate. Aim of the present study is to explore, in a multicenter setting, the rate of post-cardiac injury syndromes (PCIS) and pericardial ...
Pasquale Paolisso, Antonio Brucato, Edoardo Conte   +2 more
exaly   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Pericardial effusion with pembrolizumab

Journal of Oncology Pharmacy Practice, 2022
Introduction The treatment of non-small cell lung cancer (NSCLC) has profoundly changed on account of the arrival of new therapies, like immunotherapy. Within this group of drugs, those aimed at the programmed cell death-1 or programmed cell death ligand-1(PD1/PDL-1) are very relevant, for example, Pembrolizumab.
Laura Fernández Madrigal, Olalla Montero Pérez, Maria Yeray Rodriguez Garcés, Ángel Inoriza Rueda, Francisco Javier Martínez Marcos   +4 more
openaire   +2 more sources

PERICARDIAL EFFUSION IN HYPOTHYROIDISM

Clinical Endocrinology, 1980
SUMMARYThirty‐nine patients with untreated hypothyroidism have been examined using echocardiography for the presence of a pericardial effusion. Effusions were present in twelve patients who tended to be more severely hypothyroid. Plasma creatine phosphokinase and lactate dehydrogenase levels were higher in the presence of an effusion.
C A, Hardisty, D R, Naik, D S, Munro
openaire   +2 more sources